GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Cordlife Group Ltd (SGX:P8A) » Definitions » EBIT

Cordlife Group (SGX:P8A) EBIT : S$-18.59 Mil (TTM As of Dec. 2024)


View and export this data going back to 2012. Start your Free Trial

What is Cordlife Group EBIT?

Cordlife Group's earnings before interest and taxes (EBIT) for the six months ended in Dec. 2024 was S$-5.16 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Dec. 2024 was S$-18.59 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Cordlife Group's annualized ROC % for the quarter that ended in Dec. 2024 was -13.61%. Cordlife Group's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2024 was -47.85%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Cordlife Group's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2024 was 111.73%.


Cordlife Group EBIT Historical Data

The historical data trend for Cordlife Group's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cordlife Group EBIT Chart

Cordlife Group Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only 7.89 7.21 5.66 4.53 -18.59

Cordlife Group Semi-Annual Data
Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.34 2.87 1.66 -13.42 -5.16

Competitive Comparison of Cordlife Group's EBIT

For the Diagnostics & Research subindustry, Cordlife Group's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cordlife Group's EV-to-EBIT Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Cordlife Group's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Cordlife Group's EV-to-EBIT falls into.



Cordlife Group EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was S$-18.59 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Cordlife Group  (SGX:P8A) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Cordlife Group's annualized ROC % for the quarter that ended in Dec. 2024 is calculated as:

ROC % (Q: Dec. 2024 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Jun. 2024 ) + Invested Capital (Q: Dec. 2024 ))/ count )
=-16.052 * ( 1 - -20.52% )/( (144.017 + 140.187)/ 2 )
=-19.3458704/142.102
=-13.61 %

where

Note: The Operating Income data used here is two times the semi-annual (Dec. 2024) data.

2. Joel Greenblatt's definition of Return on Capital:

Cordlife Group's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2024 is calculated as:

ROC (Joel Greenblatt) %(Q: Dec. 2024 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Jun. 2024  Q: Dec. 2024
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=-10.328/( ( (16.372 + max(6.228, 0)) + (17.035 + max(3.531, 0)) )/ 2 )
=-10.328/( ( 22.6 + 20.566 )/ 2 )
=-10.328/21.583
=-47.85 %

where Working Capital is:

Working Capital(Q: Jun. 2024 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(23.986 + 0.914 + 12.112) - (20.749 + 0 + 10.035)
=6.228

Working Capital(Q: Dec. 2024 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(25.162 + 0.922 + 4.286) - (16.376 + 0 + 10.463)
=3.531

When net working capital is negative, 0 is used.

Note: The EBIT data used here is two times the semi-annual (Dec. 2024) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Cordlife Group's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Dec. 2024 )
=-18.587/-16.635
=111.73 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Cordlife Group EBIT Related Terms

Thank you for viewing the detailed overview of Cordlife Group's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Cordlife Group Business Description

Traded in Other Exchanges
Address
1 Yishun Industrial Street 1, Number 06-01/09, A'Posh Bizhub, Singapore, SGP, 768160
Cordlife Group Ltd is a consumer healthcare company dedicated to safeguarding the well-being of mother and child. Cordlife has processing and storage facilities in six key markets across Asia, namely Singapore, Hong Kong, Malaysia, India, Indonesia, and the Philippines. The company has two segments - The Banking segment, which comprises cord blood, cord lining, and cord tissue services. The Diagnostics segment comprises Metascreen, which is a non-invasive metabolic screening test specially designed for newborn babies, a non-invasive prenatal testing service and Eyescreen, a paediatric eye-screening service.

Cordlife Group Headlines

No Headlines